Home › Skin Cancer › Colorado › Aurora
Skin Cancer clinical trials in Aurora, CO
4 studies for Skin Cancer are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
RecruitingPhase 3
- University of Colorado Cancer Center, Aurora
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
RecruitingPhase 2/3
- University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
RecruitingPhase 1/2
- University of Colorado Cancer Center, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Aurora
About Skin Cancer
Try ABCDE on a mole to check for signs of skin cancer: Asymmetry, Border, Color, Diameter, Elevation. Learn more on advanced detection and treatments.
More about Skin Cancer on MedlinePlus
Skin Cancer trials in other cities
- Boston, MA8 studies
- New York City, NY7 studies
- Tampa, FL7 studies
- Pittsburgh, PA6 studies
- Salt Lake City, UT6 studies
- Washington, DC6 studies
- Los Angeles, CA5 studies
- Rochester, MN5 studies
- Houston, TX5 studies
- Edison, NJ4 studies
- Atlanta, GA4 studies
- Miami, FL4 studies
Other studies in Aurora
- Cancer (all types)35 studies
- Colorectal Cancer32 studies
- Non-Small Cell Lung Cancer30 studies
- Breast Cancer26 studies
- Metastatic Cancer25 studies
- Ovarian Cancer24 studies
- Type 1 Diabetes23 studies
- Obesity21 studies
- Lung Cancer19 studies
- Heart Failure18 studies
- Melanoma18 studies
- Prostate Cancer17 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.